HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pascale Reverdiau Selected Research

tissue-factor-pathway inhibitor 2 (PP5)

1/2021Tissue factor pathway inhibitor 2 is a potent kallikrein-related protease 12 inhibitor.
1/2013Beneficial role of overexpression of TFPI-2 on tumour progression in human small cell lung cancer.
2/2011TFPI-2 silencing increases tumour progression and promotes metalloproteinase 1 and 3 induction through tumour-stromal cell interactions.
1/2009Transient RNA silencing of tissue factor pathway inhibitor-2 modulates lung cancer cell invasion.
5/2007Influence of MMP-2 and MMP-9 promoter polymorphisms on gene expression and clinical outcome of non-small cell lung cancer.
7/2003Transcriptional silencing of the TFPI-2 gene by promoter hypermethylation in choriocarcinoma cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Pascale Reverdiau Research Topics

Disease

8Neoplasms (Cancer)
01/2021 - 07/2003
6Lung Neoplasms (Lung Cancer)
09/2014 - 05/2007
4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
09/2014 - 07/2008
3Pathologic Processes
01/2021 - 07/2011
3Neoplasm Metastasis (Metastasis)
01/2013 - 01/2009
2Lung Diseases (Lung Disease)
01/2018 - 09/2011
1Chronic Obstructive Pulmonary Disease (COPD)
10/2021
1Inflammation (Inflammations)
10/2021
1Airway Remodeling
10/2021
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2013
1Uterine Cervical Neoplasms (Cancer of the Cervix)
02/2009
1Carcinoma (Carcinomatosis)
07/2008
1Choriocarcinoma
07/2003
1Trophoblastic Neoplasms (Trophoblastic Tumor)
07/2003

Drug/Important Bio-Agent (IBA)

6tissue-factor-pathway inhibitor 2 (PP5)IBA
01/2021 - 07/2003
5Peptide Hydrolases (Proteases)FDA Link
10/2021 - 07/2011
3Kallikreins (Kallikrein)IBA
01/2018 - 07/2011
3Thromboplastin (Tissue Factor)IBA
01/2009 - 07/2003
2Matrix Metalloproteinases (MMPs)IBA
02/2011 - 01/2009
2Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA
05/2007 - 07/2003
1Protease Inhibitors (Protease Inhibitor)IBA
10/2021
1Biomarkers (Surrogate Marker)IBA
01/2018
1LigandsIBA
09/2014
1ErbB Receptors (EGF Receptor)IBA
09/2014
1PAR-2 ReceptorIBA
09/2014
1AerosolsIBA
09/2011
1Monoclonal AntibodiesIBA
09/2011
1Edetic Acid (EDTA)FDA Link
09/2011
1Immunoglobulin G (IgG)IBA
09/2011
1Cetuximab (Erbitux)FDA Link
09/2011
1Serine Proteases (Serine Protease)IBA
07/2011
1IntegrinsIBA
02/2011
1CollagenIBA
02/2011
1Laminin (Merosin)IBA
02/2011
1RNA (Ribonucleic Acid)IBA
02/2011
1Conditioned Culture MediaIBA
02/2011
1Small Interfering RNA (siRNA)IBA
02/2009
1Oncogene Proteins (Oncogene Protein)IBA
02/2009
1Proteins (Proteins, Gene)FDA Link
02/2009
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
07/2008
1Messenger RNA (mRNA)IBA
07/2008
1Codon (Codons)IBA
07/2008
1FibrinolysinFDA Link
05/2007
1hydrogen sulfite (bisulfite)IBA
07/2003